Cargando…

Preparation and development of equine hyperimmune globulin F(ab′)(2) against severe acute respiratory syndrome coronavirus

Aim: The resurgence of severe acute respiratory syndrome (SARS) is still a threat because the causative agent remaining in animal reservoirs is not fully understood, and sporadic cases continue to be reported. Developing high titers of anti‐SARS hyperimmune globulin to provide an alternative pathway...

Descripción completa

Detalles Bibliográficos
Autores principales:	LU, Jai‐hai, GUO, Zhong‐min, HAN, Wen‐yu, WANG, Guo‐ling, ZHANG, Ding‐mei, WANG, Yi‐fei, SUN, Sheng‐yun, YANG, Qin‐he, ZHENG, Huan‐ying, WONG, Bing L, ZHONG, Nan‐shan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Science Pty 2005
Materias:	ORIGINAL ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091834/ https://www.ncbi.nlm.nih.gov/pubmed/16297347 http://dx.doi.org/10.1111/j.1745-7254.2005.00210.x

Ejemplares similares

Passive immunotherapy for influenza A H5N1 virus infection with equine hyperimmune globulin F(ab')(2 )in mice
por: Lu, Jiahai, et al.
Publicado: (2006)

Hyperimmune Globulins for the Management of Infectious Diseases
por: Pati, Ilaria, et al.
Publicado: (2023)

In vitro and in vivo activity of hyperimmune globulin preparations against multiresistant nosocomial pathogens
por: Rossmann, F. S., et al.
Publicado: (2014)

GAMMA GLOBULIN TURNOVER IN RABBITS BEFORE AND DURING HYPERIMMUNIZATION
por: Andersen, Stig Bryde, et al.
Publicado: (1964)

Herd immunity: hyperimmune globulins for the 21st century
por: Elliott, Sarah TC, et al.
Publicado: (2018)

Hyperimmune Globulin for Severely Immunocompromised Patients Hospitalized With Coronavirus Disease 2019: A Randomized, Controlled Trial
por: Huygens, Sammy, et al.
Publicado: (2022)

Generation of recombinant hyperimmune globulins from diverse B-cell repertoires
por: Keating, Sheila M., et al.
Publicado: (2021)

Biweekly Versus Monthly Hyperimmune Globulin Therapy for Primary Cytomegalovirus Infection in Pregnancy
por: Schirwani-Hartl, Nawa, et al.
Publicado: (2023)

Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development
por: de Alwis, Ruklanthi, et al.
Publicado: (2020)

Can hyperimmune anti-CMV globulin substitute for convalescent plasma for treatment of COVID-19?
por: Basic-Jukic, Nikolina
Publicado: (2020)

Cytomegalovirus mismatch after heart transplantation: Impact of antiviral prophylaxis and intravenous hyperimmune globulin
por: Immohr, Moritz B., et al.
Publicado: (2021)

Production of anti‐SARS‐CoV‐2 hyperimmune globulin from convalescent plasma
por: Vandeberg, Peter, et al.
Publicado: (2021)

Equine hyperimmune serum protects mice against Clostridium difficile spore challenge
por: Yan, Weiwei, et al.
Publicado: (2014)

Treatment with hyperimmune equine immunoglobulin or immunoglobulin fragments completely protects rodents from Ebola virus infection
por: Zheng, Xuexing, et al.
Publicado: (2016)

RATES OF ANTIBODY SYNTHESIS DURING FIRST, SECOND, AND HYPERIMMUNE RESPONSES OF RABBITS TO BOVINE GAMMA GLOBULIN
por: Dixon, Frank J., et al.
Publicado: (1956)

Resolution of Mild Ganciclovir-Resistant Cytomegalovirus Disease with Reduced-Dose Cidofovir and CMV-Hyperimmune Globulin
por: Patel, Samir J., et al.
Publicado: (2014)

Prevention of Congenital Cytomegalovirus Infection: Review and Case Series of Valaciclovir versus Hyperimmune Globulin Therapy
por: Nigro, Giovanni, et al.
Publicado: (2023)

Production of the First Effective Hyperimmune Equine Serum Antivenom against Africanized Bees
por: Santos, Keity Souza, et al.
Publicado: (2013)

GMP Manufacturing and IND-Enabling Studies of a Recombinant Hyperimmune Globulin Targeting SARS-CoV-2
por: Mizrahi, Rena A., et al.
Publicado: (2022)

Potent Anti‐SARS‐CoV‐2 Efficacy of COVID‐19 Hyperimmune Globulin from Vaccine‐Immunized Plasma
por: Yu, Ding, et al.
Publicado: (2022)

CMV hyperimmune globulin as salvage therapy for recurrent or refractory CMV infection in children undergoing hematopoietic stem cell transplantation
por: Panesso, Melissa, et al.
Publicado: (2023)

Equine Immunoglobulin and Equine Neutralizing F(ab′)(2) Protect Mice from West Nile Virus Infection
por: Cui, Jiannan, et al.
Publicado: (2016)

High Efficacy of Therapeutic Equine Hyperimmune Antibodies Against SARS-CoV-2 Variants of Concern
por: Moreira-Soto, Andres, et al.
Publicado: (2021)

Opsonization but not pretreatment of equine macrophages with hyperimmune plasma nonspecifically enhances phagocytosis and intracellular killing of Rhodococcus equi
por: Harvey, Aja B., et al.
Publicado: (2020)

Standard treatment–refractory cytomegalovirus encephalitis unmasked by immune reconstitution inflammatory syndrome and successfully treated with virus‐specific hyperimmune globulin
por: Maximova, Natalia, et al.
Publicado: (2020)

Human Intramuscular Hyperimmune Gamma Globulin (hIHGG) Anti-SARS-CoV-2—Characteristics of Intermediates and Final Product
por: Lachert, Elzbieta, et al.
Publicado: (2022)

Equine immunoglobulin F(ab')(2) fragments protect cats against feline calicivirus infection
por: Cui, Zhanding, et al.
Publicado: (2019)

Immune Maturation Effects on Viral Neutralization and Avidity of Hyperimmunized Equine Anti-SARS-CoV-2 Sera
por: González Viacava, Myriam Belén, et al.
Publicado: (2022)

Evaluation of the safety, immunogenicity and pharmacokinetics of equine anti-SARS–CoV F(ab′)(2) in macaque()
por: Xu, Yunsheng, et al.
Publicado: (2007)

Feasibility of identifying plasma donors with high measles neutralizing antibody concentrations for the use of producing a measles hyperimmune globulin for postexposure prophylaxis
por: Lackner, Cornelia, et al.
Publicado: (2022)

Therapeutic equine hyperimmune antibodies with high and broad-spectrum neutralizing activity protect rodents against SARS-CoV-2 infection
por: Li, Entao, et al.
Publicado: (2023)

Prevention and Treatment of Influenza with Hyperimmune Bovine Colostrum Antibody
por: Ng, Wy Ching, et al.
Publicado: (2010)

COVID-19 and Hyperimmune sera: A feasible plan B to fight against coronavirus
por: da Costa, Camila B.P., et al.
Publicado: (2021)

Prophylactic Efficacy of Equine Immunoglobulin F(ab′)(2) Fragments Against Feline Parvovirus
por: Liu, Jinfeng, et al.
Publicado: (2021)

ANTI-DNA ANTIBODIES IN HYPERIMMUNIZED RABBITS
por: Christian, Charles L., et al.
Publicado: (1965)

PEGylation Prolongs the Half-Life of Equine Anti-SARS-CoV-2 Specific F(ab’)(2)
por: Xu, Mengyuan, et al.
Publicado: (2023)

RHEUMATOID FACTOR PROPERTIES OF HYPERIMMUNE RABBIT SERA
por: Christian, Charles L.
Publicado: (1963)

Equine Coronavirus Infection
por: Pusterla, Nicola, et al.
Publicado: (2016)

Successful use of equine anti-thymocyte globulin (ATGAM) for fulminant myocarditis secondary to nivolumab therapy
por: Tay, Rebecca Y, et al.
Publicado: (2017)

Anti-SARS-CoV-2 hyperimmune plasma workflow
por: Annamaria, Petrungaro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2dbieaelts7ut1n8ppgshsirr4